These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34917126)

  • 1. A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.
    Liu R; Jiang Z; Kong W; Zheng S; Dai T; Wang G
    Front Genet; 2021; 12():730732. PubMed ID: 34917126
    [No Abstract]   [Full Text] [Related]  

  • 2. STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment.
    Pu Z; Liu J; Liu Z; Peng F; Zhu Y; Wang X; He J; Yi P; Hu X; Fan X; Chen J
    Cancer Cell Int; 2022 Oct; 22(1):314. PubMed ID: 36224658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
    Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
    Front Genet; 2021; 12():779554. PubMed ID: 34880908
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
    Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
    Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
    Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
    Front Genet; 2021; 12():717319. PubMed ID: 34899826
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma.
    Zheng Z; Wen Y; Nie K; Tang S; Chen X; Lan S; Pan J; Jiang K; Jiang X; Liu P; Yan Y; Liu F; Liu Y; Li P
    Hepatol Res; 2020 Oct; 50(10):1151-1163. PubMed ID: 32567216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma.
    Su L; Zhang G; Kong X
    Front Oncol; 2021; 11():642563. PubMed ID: 34336648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma.
    Zhang S; Li X; Zhang X; Zhang S; Tang C; Kuang W
    Front Mol Biosci; 2021; 8():781427. PubMed ID: 35047554
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma.
    Li W; Mei M; Liu T; Zhang S; Wang Z; Suo Y; Wang S; Liu Y; Zhang N; Lu W
    Int J Gen Med; 2022; 15():437-449. PubMed ID: 35046705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma.
    Wang Z; Rehman AU; Qin X; Zhu C; Wu S
    Dis Markers; 2022; 2022():7545666. PubMed ID: 35592706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
    Tang Y; Zeng Z; Wang J; Li G; Huang C; Dong X; Feng Z
    Am J Transl Res; 2020; 12(4):1184-1202. PubMed ID: 32355535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 18. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.